Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway (vol 413, pg 109, 2016)

被引：0
|
作者：
Zhang, Yifan [1 ]
Shan, Shengzhou [1 ]
Wang, Jing [1 ]
Cheng, Xinyu [2 ]
Yi, Bo [3 ]
Zhou, Jia [1 ]
Li, Qingfeng [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ninth Peoples Hosp, Dept Plast & Reconstruct Surg, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China
[2] Jiangxi Canc Hosp, Sch Med, Renji Hosp, Dept Anesthesiol, Shanghai, Peoples R China
[3] Anhui Med Univ, Beijing Mil Reg, Clin Coll Gen Hosp, Hefei, Peoples R China
来源：
MOLECULAR AND CELLULAR BIOCHEMISTRY | 2020年 / 468卷 / 1-2期
关键词：
D O I：
10.1007/s11010-020-03702-0
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
In the original article, Figs. 3b, 4a, c and 5d were published incorrectly. The correct version of the figures are provided in this correction.
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [1] Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway
    Yifan Zhang
    Shengzhou Shan
    Jing Wang
    Xinyu Cheng
    Bo Yi
    Jia Zhou
    Qingfeng Li
    Molecular and Cellular Biochemistry, 2016, 413 : 109 - 118
  • [2] Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway
    Zhang, Yifan
    Shan, Shengzhou
    Wang, Jing
    Cheng, Xinyu
    Yi, Bo
    Zhou, Jia
    Li, Qingfeng
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2016, 413 (1-2) : 109 - 118
  • [3] Correction to: Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway
    Yifan Zhang
    Shengzhou Shan
    Jing Wang
    Xinyu Cheng
    Bo Yi
    Jia Zhou
    Qingfeng Li
    Molecular and Cellular Biochemistry, 2020, 468 : 195 - 196
  • [4] Dihydroartemisinin inhibits endothelial cell migration via the TGF-β1/ALK5/SMAD2 signaling pathway
    Guo, Ling
    Wen, Xiaoqing
    Hou, Yinglong
    Sun, Rong
    Zhang, Liang
    Liu, Fuhong
    Liu, Ju
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)
  • [5] Role of ALK5/SMAD2/3 signaling in the regulation of NOX expression in cerebral ischemia/reperfusion injury
    Lou, Zheng
    Wang, Ai-Ping
    Duan, Xiao-Ming
    Hu, Guo-Huang
    Zuo, Mei-Ling
    Yang, Zhong-Bao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (03) : 1671 - 1678
  • [6] Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-β/Smad2/3 signalling pathway
    Zhang, Y. F.
    Zhou, S. Z.
    Cheng, X. Y.
    Yi, B.
    Shan, S. Z.
    Wang, J.
    Li, Q. F.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (01) : 120 - 130
  • [7] Transforming growth factor β2 regulates growth and differentiation of pulp cells via ALK5/Smad2/3
    Tai, Tseng-Fang
    Chan, Chiu-Po
    Lin, Chiu-Chun
    Chen, Lin-I
    Jeng, Jiiang-Huei
    Chang, Mei-Chi
    JOURNAL OF ENDODONTICS, 2008, 34 (04) : 427 - 432
  • [8] Honokiol Alleviates Hypertrophic Scar by Targeting Transforming Growth Factor-β/Smad2/3 Signaling Pathway
    Zhao, Danyang
    Wang, Yu
    Du, Chao
    Shan, Shengzhou
    Zhang, Yifan
    Du, Zijing
    Han, Dong
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [9] Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway
    Wu, Xue-ping
    Wang, Hai-jie
    Wang, Yong-li
    Shen, Hao-ran
    Tan, Yu-zhen
    EXPERIMENTAL CELL RESEARCH, 2018, 362 (01) : 17 - 27
  • [10] GDF11 inhibits adipogenesis and improves mature adipocytes metabolic function via WNT/β-catenin and ALK5/SMAD2/3 pathways
    Frohlich, Jan
    Kovacovicova, Kristina
    Raffaele, Marco
    Virglova, Tereza
    Cizkova, Eliska
    Kucera, Jan
    Bienertova-Vasku, Julie
    Wabitsch, Martin
    Peyrou, Marion
    Bonomini, Francesca
    Rezzani, Rita
    Chaldakov, George N.
    Tonchev, Anton B.
    Di Rosa, Michelino
    Blavet, Nicolas
    Hejret, Vaclav
    Vinciguerra, Manlio
    CELL PROLIFERATION, 2022, 55 (10)
12345